These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

3532 related articles for article (PubMed ID: 17414758)

  • 1. [F-18]fluorodeoxyglucose positron emission tomography and positron emission tomography: computed tomography in recurrent and metastatic cholangiocarcinoma.
    Jadvar H; Henderson RW; Conti PS
    J Comput Assist Tomogr; 2007; 31(2):223-8. PubMed ID: 17414758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FDG-positron emission tomography/computed tomography and standardized uptake value in the primary diagnosis and staging of hilar cholangiocarcinoma.
    Ruys AT; Bennink RJ; van Westreenen HL; Engelbrecht MR; Busch OR; Gouma DJ; van Gulik TM
    HPB (Oxford); 2011 Apr; 13(4):256-62. PubMed ID: 21418131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Usefulness of 18F-fluorodeoxyglucose positron emission tomography in differential diagnosis and staging of cholangiocarcinomas.
    Moon CM; Bang S; Chung JB; Park SW; Song SY; Yun M; Lee JD
    J Gastroenterol Hepatol; 2008 May; 23(5):759-65. PubMed ID: 17931372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Usefulness of 18F-FDG PET in intrahepatic cholangiocarcinoma.
    Kim YJ; Yun M; Lee WJ; Kim KS; Lee JD
    Eur J Nucl Med Mol Imaging; 2003 Nov; 30(11):1467-72. PubMed ID: 14579085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical role of 18F-FDG PET-CT in suspected and potentially operable cholangiocarcinoma: a prospective study compared with conventional imaging.
    Kim JY; Kim MH; Lee TY; Hwang CY; Kim JS; Yun SC; Lee SS; Seo DW; Lee SK
    Am J Gastroenterol; 2008 May; 103(5):1145-51. PubMed ID: 18177454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical value of F18-fluorodeoxyglucose positron emission tomography-computed tomography in patients with non-small cell lung cancer after potentially curative surgery: experience with 241 patients.
    Kanzaki R; Higashiyama M; Maeda J; Okami J; Hosoki T; Hasegawa Y; Takami M; Kodama K
    Interact Cardiovasc Thorac Surg; 2010 Jun; 10(6):1009-14. PubMed ID: 20197344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluorine-18 fluorodeoxyglucose positron emission tomography predicts lymph node metastasis, P-glycoprotein expression, and recurrence after resection in mass-forming intrahepatic cholangiocarcinoma.
    Seo S; Hatano E; Higashi T; Nakajima A; Nakamoto Y; Tada M; Tamaki N; Iwaisako K; Mori A; Doi R; Ikai I; Uemoto S
    Surgery; 2008 Jun; 143(6):769-77. PubMed ID: 18549893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical use of combined positron emission tomography and computed tomography (FDG-PET/CT) in recurrent ovarian cancer.
    Thrall MM; DeLoia JA; Gallion H; Avril N
    Gynecol Oncol; 2007 Apr; 105(1):17-22. PubMed ID: 17208284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positron emission tomography with [(18)F]fluoro-2-deoxy-D-glucose for diagnosis and staging of bile duct cancer.
    Kluge R; Schmidt F; Caca K; Barthel H; Hesse S; Georgi P; Seese A; Huster D; Berr F
    Hepatology; 2001 May; 33(5):1029-35. PubMed ID: 11343227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is combined 18F-fluorodeoxyglucose-positron emission tomography/computed tomography superior to positron emission tomography or computed tomography alone for diagnosis, staging and restaging of pancreatic lesions?
    Casneuf V; Delrue L; Kelles A; Van Damme N; Van Huysse J; Berrevoet F; De Vos M; Duyck P; Peeters M
    Acta Gastroenterol Belg; 2007; 70(4):331-8. PubMed ID: 18330088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 2-deoxy-2-[F-18]fluoro-D-glucose-positron emission tomography/computed tomography imaging evaluation of esophageal cancer.
    Jadvar H; Henderson RW; Conti PS
    Mol Imaging Biol; 2006; 8(3):193-200. PubMed ID: 16565910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of 2-[18F] fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography in the post-therapy surveillance of breast cancer.
    Chang HT; Hu C; Chiu YL; Peng NJ; Liu RS
    PLoS One; 2014; 9(12):e115127. PubMed ID: 25517451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of (18)F-fluorodeoxyglucose positron emission tomography in the diagnosis, staging, and follow-up of cholangiocarcinoma.
    Moon CM; Bang S; Chung JB
    Surg Oncol; 2011 Mar; 20(1):e10-7. PubMed ID: 19804967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical utility of F-18 FDG PET/CT in recurrent breast carcinoma.
    Manohar K; Mittal BR; Senthil R; Kashyap R; Bhattacharya A; Singh G
    Nucl Med Commun; 2012 Jun; 33(6):591-6. PubMed ID: 22334135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined [18F]Fluorodeoxyglucose positron emission tomography and computed tomography (FDG-PET/CT) for detection of recurrent, 131I-negative thyroid cancer.
    Finkelstein SE; Grigsby PW; Siegel BA; Dehdashti F; Moley JF; Hall BL
    Ann Surg Oncol; 2008 Jan; 15(1):286-92. PubMed ID: 17882493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of Klatskin's tumor in extrahepatic bile duct strictures using delayed 18F-FDG PET/CT: preliminary results for 22 patient studies.
    Reinhardt MJ; Strunk H; Gerhardt T; Roedel R; Jaeger U; Bucerius J; Sauerbruch T; Biersack HJ; Dumoulin FL
    J Nucl Med; 2005 Jul; 46(7):1158-63. PubMed ID: 16000285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implication of lymph node metastasis detected on 18F-FDG PET/CT for surgical planning in patients with peripheral intrahepatic cholangiocarcinoma.
    Park TG; Yu YD; Park BJ; Cheon GJ; Oh SY; Kim DS; Choe JG
    Clin Nucl Med; 2014 Jan; 39(1):1-7. PubMed ID: 24335565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preoperative assessment of hilar cholangiocarcinoma by dual-modality PET/CT.
    Li J; Kuehl H; Grabellus F; Müller SP; Radunz S; Antoch G; Nadalin S; Broelsch CE; Gerken G; Paul A; Kaiser GM
    J Surg Oncol; 2008 Nov; 98(6):438-43. PubMed ID: 18767120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Application of ¹⁸F-fluorodeoxyglucose positron emission tomography/computed tomography in preoperative assessment of hilar cholangiocarcinoma].
    Gu XJ; Wang BF; Liu R
    Zhonghua Yi Xue Za Zhi; 2012 May; 92(20):1409-12. PubMed ID: 22883200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of relapse in patients with peritoneal carcinomatosis after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy using F-18-FDG-PET/CT.
    Klumpp B; Schwenzer NF; Gatidis S; Koenigsrainer I; Koenigsrainer A; Beckert S; Mueller M; Claussen CD; Pfannenberg C
    Rofo; 2014 Apr; 186(4):359-66. PubMed ID: 24683168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 177.